Emerging From the Haze™- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment

Inclusion Criteria:

- Completed treatment for stage 1-3 breast cancer at least two months but not more than
24 months prior to enrollment.

- Having received chemotherapy with or without radiation therapy

- Female, Age ≥18 years.

- FACT-Cog score less than 59 on the Perceived Cognitive Impairment subscale

- Eligible after 2 months of completing all their active cancer treatment with the
exception of long-term hormonal treatments or trastuzumab.

- Subjective complaint of cognitive concerns at time of enrollment

- Must be able to understand and communicate proficiently in English

- Ability to understand and the willingness to sign a written informed consent.

- Agree to complete study surveys

Exclusion Criteria:

- Patients who have significant personality disorders or unstable psychiatric disorders
(including active major depression, substance abuse, psychosis or bipolar disorder) as
assessed by the interviewing clinician

- Patients with known brain metastases, history of brain metastases or radiation to the
brain.

- Patients with a history of stroke or other pre-existing neurological condition that
may contribute to cognitive dysfunction.

- Non-English speakers

- Receiving treatment for another malignancy other than breast cancer

- Uncontrolled intercurrent illness including, but not limited to, ongoing or active
infection, chronic anemia, uncontrolled hypothyroidism, symptomatic congestive heart
failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric
illness/social situations that would limit compliance with study requirements.